We hypothesize that a comprehensive exploration of TP53 dynamics in diverse cancer landscapes will unveil novel diagnostic and prognostic biomarkers, identify potential therapeutic targets, and deepen our understanding of the molecular mechanisms driving cancer development and progression. This evidence concerns the gene TP53 and cancer.